BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders

Karacetin, G.; BAYOĞLU, BURCU; Soylemez, T.; Topal, M.; Koc, E.; Tekden, M.; Ermis, C.; Demir, T.; Yuksel, M.; Ercan, E.; Erkiran, M.; Sezgin, S.; Cengiz, M.

doi:10.1016/j.ejpsy.2021.04.002

BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders

Copy For Citation

Karacetin G., BAYOĞLU B., Soylemez T. E., Topal M., Koc E. B., Tekden M., ...More

EUROPEAN JOURNAL OF PSYCHIATRY, vol.36, no.1, pp.26-34, 2022 (SSCI)

Publication Type: Article / Article
Volume: 36 Issue: 1
Publication Date: 2022
Doi Number: 10.1016/j.ejpsy.2021.04.002
Journal Name: EUROPEAN JOURNAL OF PSYCHIATRY
Journal Indexes: Social Sciences Citation Index (SSCI), Scopus, ASSIA, BIOSIS, EMBASE, Psycinfo, DIALNET
Page Numbers: pp.26-34
Keywords: DRD2/ANKK1 Taq1A genotypes, BDNF Val66Met genotypes, Early-onset schizophrenia, NEUROTROPHIC FACTOR BDNF, D2 RECEPTOR GENE, SERUM-LEVELS, TAQ1A POLYMORPHISM, NO ASSOCIATION, CANNABIS USE, KINASE GENE, DRD2, METAANALYSIS, RISK
Dokuz Eylül University Affiliated: Yes

Abstract

Background and Objectives: To investigate the clinical characteristics of adolescents with early-onset full psychotic disorders either with Brain-derived neurotrophic factor (BDNF) Val66Met (rs6265) or DRD2/ANKK1 Taq1A (rs1800497) polymorphisms.